Investing Ideas
/
Italian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Italian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Philogen

Market Cap: €842.1m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases.

PHIL

€20.90

4.5%

14.5%